Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
After an initial 60 weeks on Zepbound at the MTD, participants either continued on the MTD, reduced the dose to 5 mg, or received a placebo
They do not respond to other G protein-coupled receptor (GPCR)-activating hormones, such as GIP (glucose-dependent insulinotropic polypeptide) or glucagon
Follow label directions or guidance from your healthcare professional
, a panel of experts will discuss the relative risks and strategies for mitigating the severe side effects of GLP-1 receptor agonists in the treatment of obesity
Type 2 diabetes (formulation R2) Starting (Day 1 to 30): 1.5 mg once daily for 30 days (this dosage is not effective for glycemic control) Escalation and Maintenance Dosage: Days 31 to 60: Increase the dosage to 4 mg orally once daily Day 61 and on: If blood sugars are controlled, continue 4 mg once daily
US$ 21.30
US$ 27.29
US$ 24.99
